Posted by Clinical Lab Products | Nov 17, 2008 | Cancer, Miscellaneous |
A 2008 survey of chronically ill adults in Western countries found major differences in health care access, safety, and efficiency, with US patients at high risk of forgoing care because of costs.
Read MorePosted by Clinical Lab Products | Oct 29, 2008 | Cancer, Miscellaneous |
Biosystems International has received venture capital amounting to $4.6 million to foster research and development of lung, colon, and breast cancer diagnostics to be marketed in 2010.
Read MorePosted by Clinical Lab Products | Oct 13, 2008 | Cancer, Miscellaneous, Osteoporosis |
Existing recommendations for treating vitamin D deficiency in children with cystic fibrosis are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Childrens Center.
Read MorePosted by Clinical Lab Products | Sep 2, 2008 | Cancer, Miscellaneous |
DxS has signed a non-exclusive global licensing agreement with the Wellcome Trust. DxS will provide a research test for use in clinical trials to detect the presence of the V600E B-RAF mutation, which is found in melanomas, lung and thyroid cancers.
Read MorePosted by Clinical Lab Products | Aug 25, 2008 | Cancer, Miscellaneous |
Scientists have discovered gene mutations that are the main cause of the inherited version of the childhood cancer neuroblastoma. In addition, the researchers found that the same mutations play a significant role in high-risk forms of non-inherited neuroblastoma, the more common form of the disease.
Read More